You're referring to PDA Technical Report 82, which focuses on the measurement of solid content in pharmaceutical products.
LER occurs when endotoxins—potentially dangerous pyrogens from Gram-negative bacteria—become undetectable by standard Limulus Amebocyte Lysate (LAL) tests. This masking typically happens in biological medicinal products containing: (e.g., polysorbate). Chelating agents (e.g., citrate or phosphate buffers). High protein concentrations found in complex biologics. Regulatory and Industry Importance pda technical report 82
Do not use the standard USP validation protocol. Create a dedicated protocol titled "LER Evaluation per PDA TR 82." You're referring to PDA Technical Report 82, which
Today, TR 82 is the gold standard for meeting regulatory expectations, ensuring that when we say a medicine is "pyrogen-free," it truly is. Even now, experts are working on revisions to the report to keep up with the newest biological therapies. PDA technical report on low endotoxin recovery | Lonza Chelating agents (e